Ophthalmology · Rochester, NY
NPI
1902986938
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
890 Westfall Rd, Suite E
Rochester, NY, 14618
Phone (585) 473-6700
Groups this clinician bills Medicare through
Medicare paid, 2024
$45K
446 services
Medicare patients, 2024
145
Average age 72
Drug cost, 2024
$158K
2,572 prescriptions
Company payments, 2025
$4,296
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by O G Zazulak was code 92012 (ophthalmological e&m), 176 times for 85 patients. In total O G Zazulak billed 446 services in 31 codes, and Medicare paid $45K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-06-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92012 Ophthalmological E&M | Office | 176 | 85 | $61.70 | $11K |
| 92014 Ophthalmological E&M | Office | 126 | 118 | $66.40 | $8,366 |
| 92083 Vision, Hearing, and Speech Services | Office | 22 | 22 | $41.74 | $918 |
| 92004 Ophthalmological E&M | Office | 16 | 16 | $67.01 | $1,072 |
By year: 2022 $62K for 534 services; 2023 $51K for 533 services; 2024 $45K for 446 services.
Medicare prescription drug claims, 2024
In 2024, the drug O G Zazulak prescribed most often to Medicare patients was Latanoprost, with 775 prescriptions and refills. In total O G Zazulak wrote 2,572 Medicare prescriptions that cost $158K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 775 | 1,274 | 156 | $6,790 |
| Timolol Maleate Generic | 340 | 697 | 88 | $4,713 |
| Brimonidine Tartrate Generic | 153 | 335 | 44 | $6,024 |
| Prednisolone Acetate Generic | 148 | 210 | 81 | $7,450 |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 132 | 154 | 77 | $5,501 |
| Lumigan Bimatoprost | 105 | 160 | 21 | $37K |
| Ciprofloxacin Hcl Generic | 101 | 101 | 71 | $968 |
| Dorzolamide Hcl Generic | 96 | 215 | 28 | $2,217 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 93 | 185 | 25 | $1,489 |
| Ketorolac Tromethamine Generic | 78 | 93 | 28 | $1,586 |
| Doxycycline Hyclate Generic | 58 | 71 | 15 | $1,897 |
| Bimatoprost Generic | 55 | 105 | 14 | $7,079 |
| Brinzolamide Generic | 51 | 98 | 12 | $8,871 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 41 | 45 | 30 | $829 |
| Rhopressa Netarsudil Mesylate | 36 | 46 | 11 | $13K |
Brand drugs: 844 claims; generic drugs: 1,728 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid O G Zazulak $4,296 ($4,296 in general payments such as food, travel and fees) from 6 companies. The largest payer was Sight Sciences, Inc. with $3,800.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.